SCHEMBL4591704

SCHEMBL4591704

CC1(O)CCN(Cc2ccc(Br)cc2)CC1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
POLB P06746 2/20 0.44
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
BACE1 P56817 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
MMP1 P03956 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
ADAM17 P78536 1/20 0.40
TNIK Q9UKE5 1/20 0.40
GPR183 P32249 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4481641 0.85 OPRL1 (0.54) ALDH1A1POLBMEN1KMT2ALMNA
SCHEMBL16659923 0.85 OPRL1 (0.54) ALDH1A1POLBMEN1KMT2ALMNA
SCHEMBL5155047 0.85 OPRL1 (0.54) ALDH1A1POLBMEN1KMT2ALMNA
SCHEMBL4591580 0.80 ALDH1A1 (0.54) ALDH1A1KDM4EPOLBLMNAHPGD
SCHEMBL1427542 0.76 ALDH1A1 (0.58) ALDH1A1KDM4EPOLBLMNAHPGD
SCHEMBL1239292 0.73 ALDH1A1 (0.57) ALDH1A1KDM4EBCHEACHEBACE1
SCHEMBL1239295 0.73 ALDH1A1 (0.57) ALDH1A1KDM4EBCHEACHEBACE1
SCHEMBL1241903 0.73 ALDH1A1 (0.57) ALDH1A1KDM4EBCHEACHEBACE1
SCHEMBL26656812 0.73 ALDH1A1 (0.54) ALDH1A1KDM4EPOLBLMNAHPGD
SCHEMBL22804732 0.73 ALDH1A1 (0.50) ALDH1A1KDM4EPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943231-A1 (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-07-16 EP disclosed
US-20070111981-A1 New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds ROTH GERALD J 2007-05-17 US disclosed
WO-2007048802-A1 (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070111981-A1 New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds MCHR1, GPR119, MCHR2 ALDH1A1 3960/4885KDM4E 1313/4885POLB 3623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.